ECSP024374A - Derivados del 4,5-dihidro-tiazol-2-ylamina y sus usos como inhibidores de no sintetasa - Google Patents
Derivados del 4,5-dihidro-tiazol-2-ylamina y sus usos como inhibidores de no sintetasaInfo
- Publication number
- ECSP024374A ECSP024374A EC2002004374A ECSP024374A ECSP024374A EC SP024374 A ECSP024374 A EC SP024374A EC 2002004374 A EC2002004374 A EC 2002004374A EC SP024374 A ECSP024374 A EC SP024374A EC SP024374 A ECSP024374 A EC SP024374A
- Authority
- EC
- Ecuador
- Prior art keywords
- derivatives
- ylamina
- synthease
- tiazol
- dihidro
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/18—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Dermatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Vascular Medicine (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
Abstract
El presente invento concierne las composiciones farmacéuticas que contienen como principio activo un derivado del 4,5-dihidro- 1,3-tiazol-2-y lamina de fórmula (1), en donde R representa un radical -alq-S-alq-Ar, fenilo o fenil I sustituido por alcoxi o halógeno o una de sus sales farmacéuticamente aceptadas, los nuevos derivados de fórmula (1) y su preparación. Estos compuestos son útiles para prevenir y tratar enfermedades en las que una producción anormal de monóxido de nitrógeno (NO) por efecto de NO-sintetasa inducible (NOS-2) está implicada.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0007396A FR2810036B1 (fr) | 2000-06-09 | 2000-06-09 | Derives de 4,5-dihydro-1,3-thiazol-2-ylamine, leur preparation et les compositions phamarceutiques les contenant |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP024374A true ECSP024374A (es) | 2003-02-06 |
Family
ID=8851133
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EC2002004374A ECSP024374A (es) | 2000-06-09 | 2002-12-09 | Derivados del 4,5-dihidro-tiazol-2-ylamina y sus usos como inhibidores de no sintetasa |
Country Status (27)
Country | Link |
---|---|
EP (1) | EP1299103B1 (es) |
JP (1) | JP4171297B2 (es) |
KR (1) | KR20030017990A (es) |
CN (1) | CN1441673A (es) |
AP (1) | AP2002002707A0 (es) |
AT (1) | ATE305298T1 (es) |
AU (2) | AU6612301A (es) |
BR (1) | BR0111543A (es) |
CA (1) | CA2411572C (es) |
DE (1) | DE60113686T2 (es) |
DK (1) | DK1299103T3 (es) |
DZ (1) | DZ3366A1 (es) |
EA (1) | EA200300009A1 (es) |
EC (1) | ECSP024374A (es) |
ES (1) | ES2246327T3 (es) |
FR (1) | FR2810036B1 (es) |
HR (1) | HRP20020971A2 (es) |
HU (1) | HUP0300996A3 (es) |
IL (1) | IL153327A0 (es) |
MA (1) | MA25815A1 (es) |
MX (1) | MXPA02012072A (es) |
NO (1) | NO20025885L (es) |
NZ (1) | NZ522967A (es) |
OA (1) | OA12285A (es) |
PL (1) | PL360282A1 (es) |
WO (1) | WO2001093867A1 (es) |
ZA (1) | ZA200209770B (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005063732A1 (en) * | 2003-12-23 | 2005-07-14 | Microbia, Inc. | Compounds and methods for the treatment of asthma |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU5533094A (en) * | 1992-11-27 | 1994-06-22 | Wellcome Foundation Limited, The | Enzyme inhibitors |
JPH09504028A (ja) * | 1993-10-21 | 1997-04-22 | ジー.ディー.サール アンド カンパニー | 酸化窒素シンターゼ抑制剤として有用なアミジノ誘導体 |
WO1996014842A1 (en) * | 1994-11-15 | 1996-05-23 | Merck & Co., Inc. | Substituted heterocycles as inhibitors of nitric oxide synthase |
-
2000
- 2000-06-09 FR FR0007396A patent/FR2810036B1/fr not_active Expired - Fee Related
-
2001
- 2001-06-07 KR KR1020027016786A patent/KR20030017990A/ko not_active Application Discontinuation
- 2001-06-07 IL IL15332701A patent/IL153327A0/xx unknown
- 2001-06-07 NZ NZ522967A patent/NZ522967A/en unknown
- 2001-06-07 WO PCT/FR2001/001759 patent/WO2001093867A1/fr active IP Right Grant
- 2001-06-07 JP JP2002501440A patent/JP4171297B2/ja not_active Expired - Fee Related
- 2001-06-07 DZ DZ013366A patent/DZ3366A1/xx active
- 2001-06-07 MX MXPA02012072A patent/MXPA02012072A/es active IP Right Grant
- 2001-06-07 OA OA1200200371A patent/OA12285A/fr unknown
- 2001-06-07 AT AT01943579T patent/ATE305298T1/de not_active IP Right Cessation
- 2001-06-07 CN CN01812587A patent/CN1441673A/zh active Pending
- 2001-06-07 AP APAP/P/2002/002707A patent/AP2002002707A0/en unknown
- 2001-06-07 DE DE60113686T patent/DE60113686T2/de not_active Expired - Lifetime
- 2001-06-07 AU AU6612301A patent/AU6612301A/xx active Pending
- 2001-06-07 CA CA002411572A patent/CA2411572C/fr not_active Expired - Fee Related
- 2001-06-07 BR BR0111543-0A patent/BR0111543A/pt not_active Application Discontinuation
- 2001-06-07 PL PL36028201A patent/PL360282A1/xx unknown
- 2001-06-07 AU AU2001266123A patent/AU2001266123B2/en not_active Ceased
- 2001-06-07 HU HU0300996A patent/HUP0300996A3/hu unknown
- 2001-06-07 EP EP01943579A patent/EP1299103B1/fr not_active Expired - Lifetime
- 2001-06-07 DK DK01943579T patent/DK1299103T3/da active
- 2001-06-07 ES ES01943579T patent/ES2246327T3/es not_active Expired - Lifetime
- 2001-06-07 EA EA200300009A patent/EA200300009A1/ru unknown
-
2002
- 2002-12-02 ZA ZA200209770A patent/ZA200209770B/en unknown
- 2002-12-06 NO NO20025885A patent/NO20025885L/no not_active Application Discontinuation
- 2002-12-06 HR HR20020971A patent/HRP20020971A2/xx not_active Application Discontinuation
- 2002-12-09 MA MA26940A patent/MA25815A1/fr unknown
- 2002-12-09 EC EC2002004374A patent/ECSP024374A/es unknown
Also Published As
Publication number | Publication date |
---|---|
ATE305298T1 (de) | 2005-10-15 |
AU2001266123B2 (en) | 2007-01-25 |
DE60113686D1 (de) | 2006-02-09 |
NO20025885D0 (no) | 2002-12-06 |
CA2411572C (fr) | 2009-11-10 |
HRP20020971A2 (en) | 2005-02-28 |
DK1299103T3 (da) | 2006-01-23 |
ES2246327T3 (es) | 2006-02-16 |
DE60113686T2 (de) | 2006-07-13 |
IL153327A0 (en) | 2003-07-06 |
WO2001093867A1 (fr) | 2001-12-13 |
EP1299103A1 (fr) | 2003-04-09 |
HUP0300996A3 (en) | 2006-02-28 |
MXPA02012072A (es) | 2004-08-19 |
FR2810036B1 (fr) | 2004-04-23 |
JP2003535135A (ja) | 2003-11-25 |
CA2411572A1 (fr) | 2001-12-13 |
AU6612301A (en) | 2001-12-17 |
AP2002002707A0 (en) | 2002-12-31 |
NZ522967A (en) | 2005-07-29 |
KR20030017990A (ko) | 2003-03-04 |
HUP0300996A2 (hu) | 2003-08-28 |
BR0111543A (pt) | 2003-07-01 |
DZ3366A1 (fr) | 2001-12-13 |
EA200300009A1 (ru) | 2003-04-24 |
PL360282A1 (en) | 2004-09-06 |
FR2810036A1 (fr) | 2001-12-14 |
EP1299103B1 (fr) | 2005-09-28 |
ZA200209770B (en) | 2004-03-02 |
CN1441673A (zh) | 2003-09-10 |
NO20025885L (no) | 2003-01-29 |
MA25815A1 (fr) | 2003-07-01 |
OA12285A (en) | 2006-05-12 |
JP4171297B2 (ja) | 2008-10-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY26872A1 (es) | Derivados de la 4- fenil piridina | |
UY26968A1 (es) | Agentes terapéuticos | |
DOP2001000170A (es) | Derivados de tiofeno utiles como agentes anticancesoros | |
GT200400116A (es) | Derivados de 2-amino-piridina utiles para el tratamiento de enfermedades. | |
DOP2010000148A (es) | Derivados bis-(sulfonilzmino) en terapia 066 | |
CR6643A (es) | Nuevos derivados de benzoimidazol utiles como agentes antiproliferativos | |
ECSP066383A (es) | Derivados de 5-fenil-4-metil-tiazol-2-il-amina como inhibidores de enzimas de cinasa fosfatidilinositol 3 (pi3) para el tratamiento de enfermedades inflamatorias de las vías respiratorias | |
PA8520301A1 (es) | Derivados biciclicos sustituidos para el tratamiento del crecimiento celular anormal | |
ES2213732T3 (es) | Nuevos esteres derivados de compuestos fenil-ciclohexil sustituidos. | |
AR046297A1 (es) | Inhibidores de la dpp - iv metodos para prepararlos y composiciones farmaceuticas que los contienen como agente activo | |
GT200100137A (es) | Pro-drogas de derivados de 4-fenil-piridina. | |
PA8591701A1 (es) | Derivados de pirrolopirimidina | |
AR029766A1 (es) | Compuesto inhibidor de quinasa y uso del mismo para preparar una composicion farmaceutica | |
PA8580301A1 (es) | Nuevos derivados de benzoimidazol utiles como agentes antiproliferativos | |
AR053554A1 (es) | Derivados de pirimidina para el tratamiento de trastornos hiperproliferativos | |
DOP2006000243A (es) | Derivados de pirazina | |
CL2021002165A1 (es) | Nuevos derivados de compuestos heterociclicos y uso de los mismos | |
ECSP088099A (es) | Nuevos derivados de la 2-azetidinona para el tratamiento de enfermedades hiperlipidémicas | |
NO20081582L (no) | Benzamidforbindelser anvendbare som histon-deacetylaseinhibitorer | |
ES2136037B1 (es) | Inhibidores de sulfamida-metaloproteasa | |
UY27803A1 (es) | Derivados de benzoxazina y usos de los mismos. | |
AR052413A1 (es) | Nuevos derivados de piridotienopiriidina | |
UY26564A1 (es) | Inhibidores del factor xa con aril - amidinas y sus derivados, y composiciones farmacéuticas que contienen los mismos | |
CL2022002975A1 (es) | Compuestos y composiciones para inhibir la actividad de hif2-alfa y sus métodos de uso | |
PA8589801A1 (es) | Aminoalcoxiindoles |